Shopping Cart
- Remove All
- Your shopping cart is currently empty
VEGF165B Protein, Human, Recombinant is expressed in Baculovirus-Insect Cells. The accession number is P15692-8.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
20 μg | $275 | 7-10 days | |
100 μg | $617 | 7-10 days | |
1 mg | $3,520 | 7-10 days |
Biological Activity | Activity testing is in progress. It is theoretically active, but we cannot guarantee it. If you require protein activity, we recommend choosing the eukaryotic expression version first. |
Description | VEGF165B Protein, Human, Recombinant is expressed in Baculovirus-Insect Cells. The accession number is P15692-8. |
Species | Human |
Expression System | Baculovirus Insect Cells |
Tag | Tag Free |
Accession Number | P15692-8 |
Synonyms | VPF,VEGF-A,VEGF,MVCD1,L-VEGF |
Construction | A DNA sequence encoding the human VEGFA (NP_001165100.1) (Met1-Asp191) was expressed. |
Protein Purity | > 95% as determined by SDS-PAGE. |
Molecular Weight | 19.1 kDa (predicted) |
Endotoxin | < 1.0 EU per μg protein as determined by the LAL method. |
Formulation | Lyophilized from sterile 100 mM Glycine, 10 mM Nacl pH 6.0. Please contact us for any concerns or special requirements. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
Reconstitution | Please refer to the lot-specific COA. |
Stability & Storage | It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
Shipping | In general, Lyophilized powders are shipping with blue ice. |
Research Background | Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF) and VEGF-A, is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is a member of the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family and often exists as a disulfide-linked homodimer. VEGF-A protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, inhibiting apoptosis and tumor growth. VEGF-A protein is also a vasodilator that increases microvascular permeability, thus it was originally referred to as vascular permeability factor.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.